Ganirelix is a competitive and selective gonadotropin releasing hormone (GnRH) antagonist. Ganirelix prevents endogenous GnRH from inducing luteinising hormone (LH) and follicle stimulating hormone release. Ganirelix counteracts Prostaglandin E2 (HY-101952)-induced detrusor overactivity, enhances Carbachol (HY-B1208)-induced detrusor contractions. Ganirelix can be used for the research of female infertility and detrusor overactivity[1][2][3].
Molecular Weight:
1570.32
Purity:
99.88
CAS Number:
[124904-93-4]
Formula:
C80H113ClN18O13
Target:
GnRH Receptor
Application Notes:
MCE Product type: Peptides
* VAT and and shipping costs not included. Errors and price changes excepted